Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today announced that researchers presented positive data on progress in its federally funded preclinical viral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE